UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 160

Sortiert nach

Abstract P5-04-28: A potential role for IL6ST mediating endocrine resistance in breast cancer via interaction with the ER signaling pathway

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-28

2019

Volltextzugriff (PDF)

Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines

Bioorganic & medicinal chemistry letters, 2012-07, Vol.22 (14), p.4681-4685

2012

Volltextzugriff (PDF)

Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer

Cancer research (Chicago, Ill.), 2005-08, Vol.65 (15), p.6789-6800

2005

Volltextzugriff (PDF)

Abstract P4-08-02: Understanding the mechanisms of action underlying the role of IL6ST, a key biomarker for prediction of response to endocrine therapy

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P4-P4-08-02

2018

Volltextzugriff (PDF)

Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen

Endocrine-related cancer, 2005-12, Vol.12 (4), p.851-866

2005

Volltextzugriff (PDF)

Abstract P3-12-24: Tumor-secreted predictive biomarkers of response to radiotherapy in breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-12-24

2019

Volltextzugriff (PDF)

Abstract P5-04-05: Targeting the pH regulatory mechanisms of breast cancer cells

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P5-P5-04-05

2016

Volltextzugriff (PDF)

Abstract P4-08-06: Modulation of hypoxia-inducible factors and the HIF transcriptional response to hypoxia by ERBB2 overexpression in the MCF7 breast cancer cell line

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-08-06

2016

Volltextzugriff (PDF)

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

British journal of cancer, 1996-02, Vol.73 (3), p.301-306

1996

Volltextzugriff (PDF)

CA125 response is associated with estrogen receptor expression in a Phase II trial of letrozole in ovarian cancer: Identification of an endocrine-sensitive subgroup

Clinical cancer research, 2002-07, Vol.8 (7), p.2233-2239

2002

Volltextzugriff (PDF)

The mechanism of action of Kahalalide F: Variable cell permeability in human hepatoma cell lines

European journal of cancer (1990), 2005-07, Vol.41 (11), p.1637-1644

2005

Volltextzugriff (PDF)

Abstract P6-07-02: A Systems Analysis of Oscillations in the MAPK Pathway Reveals New Mechanisms of Feed-Forward and Feedback Signaling Control

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-07-02

2010

Volltextzugriff (PDF)

Abstract P4-02-08: STAT Signaling in Endocrine Sensitive and Resistant Breast Cancer — A Potential Target for Therapy?

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-02-08

2010

Volltextzugriff (PDF)

Abstract P2-09-12: Phosphoproteomic Pathway Profiling of Breast Cancers for Biomarker and Target Discovery for Personalized Therapy

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-09-12

2010

Volltextzugriff (PDF)

Abstract P5-05-06: The Role of Sprouty 2 in HER2 Signaling in Breast Cancer; Decreased Expression Is Associated with Poor Outcome Including in Trastuzumab-Treated Patients

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P5-P5-05-06

2010

Volltextzugriff (PDF)

Neuregulin Expression, Function, and Signaling in Human Ovarian Cancer Cells

Clinical cancer research, 2002-12, Vol.8 (12), p.3933-3942

2002

Volltextzugriff (PDF)

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ('Iressa')

British journal of cancer, 2002-02, Vol.86 (3), p.456-462

2002

Volltextzugriff (PDF)

High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer

Annals of oncology, 1999-10, Vol.10 (10), p.1233-1240

1999

Volltextzugriff (PDF)

Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells

Carcinogenesis (New York), 2006-04, Vol.27 (4), p.729-739

2006

Volltextzugriff (PDF)

Role of TGFα stimulation of the ERK, PI3 kinase and PLCγ pathways in ovarian cancer growth and migration

Experimental cell research, 2005-03, Vol.304 (1), p.305-316

2005

Volltextzugriff (PDF)

Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer

British journal of cancer, 2001-11, Vol.85 (11), p.1753-1758

2001

Volltextzugriff (PDF)

Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas

British journal of cancer, 2005-05, Vol.92 (10), p.1927-1933

2005

Volltextzugriff (PDF)

Antisense oligonucleotide targeting of Raf-1: Importance of Raf-1 mRNA expression levels and Raf-1-dependent signaling in determining growth response in ovarian cancer

Clinical cancer research, 2004-03, Vol.10 (6), p.2100-2108

2004

Volltextzugriff (PDF)

Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer

Cancer research (Chicago, Ill.), 2001-03, Vol.61 (5), p.2169-2176

2001

Volltextzugriff (PDF)

Comparison of strategies targeting Raf‐1 mRNA in ovarian cancer

International journal of cancer, 2006-03, Vol.118 (6), p.1565-1571

2006

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(158)

Publikationsform

Sprache

Englisch
(160)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Technology
(78)
Science & Technology - Other Topics
(77)
Green & Sustainable Science & Technology
(76)
Materials Science
(76)
Materials Science, Biomaterials
(76)
Materials Science, Multidisciplinary
(76)
Life Sciences & Biomedicine
(66)
Biological And Medical Sciences
(58)
Humans
(57)
Medical Sciences
(56)
Oncology
(52)
Female
(47)
Pharmacology. Drug Treatments
(30)
Tumors
(30)
Animals
(27)
Antineoplastic Agents
(27)
Mice
(26)
Ovarian Neoplasms - Pathology
(25)
Gynecology. Andrology. Obstetrics
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract P5-04-28: A potential role for IL6ST mediating endocrine resistance in breast cancer via interaction with the ER signaling pathway

Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines

Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer

Abstract P4-08-02: Understanding the mechanisms of action underlying the role of IL6ST, a key biomarker for prediction of response to endocrine therapy

Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen

Abstract P3-12-24: Tumor-secreted predictive biomarkers of response to radiotherapy in breast cancer

Abstract P5-04-05: Targeting the pH regulatory mechanisms of breast cancer cells

Abstract P4-08-06: Modulation of hypoxia-inducible factors and the HIF transcriptional response to hypoxia by ERBB2 overexpression in the MCF7 breast cancer cell line

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

CA125 response is associated with estrogen receptor expression in a Phase II trial of letrozole in ovarian cancer: Identification of an endocrine-sensitive subgroup

The mechanism of action of Kahalalide F: Variable cell permeability in human hepatoma cell lines

Abstract P6-07-02: A Systems Analysis of Oscillations in the MAPK Pathway Reveals New Mechanisms of Feed-Forward and Feedback Signaling Control

Abstract P4-02-08: STAT Signaling in Endocrine Sensitive and Resistant Breast Cancer — A Potential Target for Therapy?

Abstract P2-09-12: Phosphoproteomic Pathway Profiling of Breast Cancers for Biomarker and Target Discovery for Personalized Therapy

Abstract P5-05-06: The Role of Sprouty 2 in HER2 Signaling in Breast Cancer; Decreased Expression Is Associated with Poor Outcome Including in Trastuzumab-Treated Patients

Neuregulin Expression, Function, and Signaling in Human Ovarian Cancer Cells

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ('Iressa')

High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer

Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells

Role of TGFα stimulation of the ERK, PI3 kinase and PLCγ pathways in ovarian cancer growth and migration

Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer

Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas

Antisense oligonucleotide targeting of Raf-1: Importance of Raf-1 mRNA expression levels and Raf-1-dependent signaling in determining growth response in ovarian cancer

Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer

Comparison of strategies targeting Raf‐1 mRNA in ovarian cancer

Suchergebnisse filtern